Leveraging Lymph Nodes With Elicio's Dr. Peter DeMuth
Business Of Biotech · 44 minutes ·

Leveraging Lymph Nodes With Elicio's Dr. Peter DeMuth

MIT-born startup Elicio Therapeutics' novel Amphiphile Technology Platform is designed to directly engage the lymphatic system in the deployment and delivery of therapeutic payloads. We caught up with Chief Scientific Officer Peter DeMuth, Ph.D.  at Elicio HQ in Boston to learn how the platform works, and how it's driving rapid clinical progress for the company's robust pipeline of therapeutic vaccines in oncology, as a cell therapy amplifier in liquid and solid tumor indications, and in prophylactic vaccines for infectious diseases like COVID-19. Dr. DeMuth also shares his journey as a young scientific founder, how he's managed the transition from academic scientist to the C-suite, and how he leans into his scientific training to make a killer home brew. 

Comments (0)

You Must Be Logged In To Comment

Similar podcasts

Leveraging Instagram

Leveraging The Link

The Dr. Peter Breggin Hour

Not Just About Dogs with Dr. Peter Dobias

Alone With Peter

Leveraging Gifts with Anquilla Bellow

Leveraging Thought Leadership

#NoFilter With Zack Peter